Respiratory Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

GlobalData, July 2011, Pages: 131

Respiratory Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData’s new report, “Respiratory Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global respiratory devices market. The report provides market landscape, competitive landscape and market trends information on the respiratory devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Positive Airway Pressure Devices, Ventilators, Nebulizers, Oxygen Concentrators, Humidifiers and Reusable Resuscitators.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within respiratory devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include ResMed Inc., Philips Respironics, Inc., Draegerwerk AG & Co. KGaA, Covidien plc, CareFusion Corporation and GE Healthcare.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the respiratory devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the respiratory devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global respiratory devices market and the factors shaping it.

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction and Overview
2.1 Introduction
2.2 Report Guidance
3 Respiratory Diseases: Overview
3.1 Asthma
3.1.1 Pathophysiology
3.1.2 Epidemiology
3.1.3 Diagnosis
3.2 Chronic Obstructive Pulmonary Disease
3.2.1 Causes and Symptoms
3.2.2 Pathophysiology
3.2.3 Epidemiology
3.2.4 Diagnosis
3.3 Sleep Apnea
3.3.1 Pathophysiology
3.3.2 Epidemiology
3.3.3 Diagnosis
4 Respiratory Devices: Overview
4.1 Respiratory Devices, Market Segmentation
4.1.1 Positive Airway Pressure Devices
4.1.2 Ventilators
4.1.3 Nebulizers
4.1.4 Oxygen Concentrators
4.1.5 Humidifiers
4.1.6 Reusable Resuscitator
5 Global Respiratory Devices: Market Characterization
5.1 Respiratory Devices Market, Global, Revenue ($m), Historic, 2003-2010
5.2 Respiratory Devices Market, Global, Revenue ($m), Forecast, 2010-2017
5.3 Respiratory Devices Market, Key Trends
5.3.1 Integration of Respiratory Care Devices with Critical Care Devices
5.3.2 Product Innovation to Improve Patient Management and Functionality
5.4 Respiratory Devices, Market Dynamics
5.4.1 Market Drivers
5.4.2 Market Restraints
6 Global Respiratory Devices Market, Analysis by Segment
6.1 Positive Airway Pressure Devices Market, Global, Revenue ($m), Historic, 2003-2010
6.2 Positive Airway Pressure Devices Market, Global, Revenue ($m), Forecast, 2010-2017
6.3 Positive Airway Pressure Devices, Market Dynamics
6.3.1 Market Driver: Availability of Reimbursement for PAP Devices in Developed Markets is Driving the Adoption
6.3.2 Market Restraint: Concerns such as Infections Associated with the Use of PAP Machines are Acting as Restraints for the Market
6.4 Ventilators Market, Global, Revenue ($m), Historic, 2003-2010
6.5 Ventilators Market, Global, Revenue ($m), Forecast, 2010-2017
6.6 Ventilators, Market Dynamics
6.6.1 Market Driver: Integration of Ventilators with Other Respiratory Care Devices and Development of Standardized Systems for both Adult and Pediatric Patients to Drive Market Growth
6.6.2 Market Restraint: High Cost of the Device is Restraining the Ventilators Market Growth
6.7 Nebulizers Market, Global, Revenue ($m), Historic, 2003-2010
6.8 Nebulizers Market, Global, Revenue ($m), Forecast, 2010-2017
6.9 Nebulizers, Market Dynamics
6.9.1 Market Driver: Advancements in Nebulizers is Driving the Market
6.9.2 Market Restraint: Price Competition from Companies in China to Lead to Lower Revenues
6.10 Oxygen Concentrators Market, Global, Revenue ($m), Historic, 2003-2010
6.11 Oxygen Concentrators Market, Global, Revenue ($m), Forecast, 2010-2017
6.12 Oxygen Concentrators, Market Dynamics
6.12.1 Market Driver: Benefits of Portable Oxygen Concentrators is Driving the Market
6.12.2 Market Restraint: High Cost of Procurement to Act as a Restraint for Oxygen Concentrators Market
6.13 Humidifiers Market, Global, Revenue ($m), Historic, 2003-2010
6.14 Humidifiers Market, Global, Revenue ($m), Forecast, 2010-2017
6.15 Humidifiers, Market Dynamics
6.15.1 Market Driver: Humidifiers use with other Respiratory Devices is Acting as a Driver for Market Growth
6.15.2 Market Restraint: Usage of Humidifiers Depend on the External Environment which is Acting as a Restraint for the Market
6.16 Reusable Resuscitators Market, Global, Revenue ($m), Historic, 2003-2010
6.17 Reusable Resuscitators Market, Global, Revenue ($m), Forecast, 2010-2017
6.18 Reusable Resuscitators, Market Dynamics
6.18.1 Market Driver: Cost Effectiveness of Reusable Resuscitators is Driving the Market
6.18.2 Market Restraint: High Risk of Side-effects in Reusable Resuscitators acts as a Restraint to the Market
7 Respiratory Devices Market, Analysis by Country Analysis, Revenue ($m), 2003 – 2017
7.1 Respiratory Devices Market, The US, Revenue ($’000), Historic, 2003-2010
7.2 Respiratory Devices Market, The US, Revenue ($’000), Forecast, 2010-2017
7.3 Respiratory Devices Market, Canada, Revenue ($’000), Historic, 2003-2010
7.4 Respiratory Devices Market, Canada, Revenue ($’000), Forecast, 2010-2017
7.5 Respiratory Devices Market, The UK, Revenue ($’000), Historic, 2003-2010
7.6 Respiratory Devices Market, The UK, Revenue ($’000), Forecast, 2010-2017
7.7 Respiratory Devices Market, Germany, Revenue ($’000), Historic, 2003-2010
7.8 Respiratory Devices Market, Germany, Revenue ($’000), Forecast, 2010-2017
7.9 Respiratory Devices Market, France, Revenue ($’000), Historic, 2003-2010
7.10 Respiratory Devices Market, France, Revenue ($’000), Forecast, 2010-2017
7.11 Respiratory Devices Market, Italy, Revenue ($’000), Historic, 2003-2010
7.12 Respiratory Devices Market, Italy, Revenue ($’000), Forecast, 2010-2017
7.13 Respiratory Devices Market, Spain, Revenue ($’000), Historic, 2003-2010
7.14 Respiratory Devices Market, Spain, Revenue ($’000), Forecast, 2010-2017
7.15 Respiratory Devices Market, Japan, Revenue ($’000), Historic, 2003-2010
7.16 Respiratory Devices Market, Japan, Revenue ($’000), Forecast, 2010-2017
7.17 Respiratory Devices Market, China, Revenue ($’000), Historic, 2003-2010
7.18 Respiratory Devices Market, China, Revenue ($’000), Forecast, 2010-2017
7.19 Respiratory Devices Market, India, Revenue ($’000), Historic, 2003-2010
7.20 Respiratory Devices Market, India, Revenue ($’000), Forecast, 2010-2017
7.21 Respiratory Devices Market, Australia, Revenue ($’000), Historic, 2003-2010
7.22 Respiratory Devices Market, Australia, Revenue ($’000), Forecast, 2010-2017
7.23 Respiratory Devices Market, Brazil, Revenue ($’000), Historic, 2003-2010
7.24 Respiratory Devices Market, Brazil, Revenue ($’000), Forecast, 2010-2017
8 Respiratory Devices Market: Strategic Competitive Assessment
8.1 Respiratory Devices, Market Opportunities and Risk Evaluation
8.1.1 Opportunities
8.1.2 Risks
8.2 Respiratory Devices, Key Market Participants
8.2.1 ResMed Inc
8.2.2 Philips Respironics, Inc.
8.2.3 Draegerwerk AG & Co. KGaA
8.2.4 Covidien plc
8.2.5 CareFusion Corporation
8.2.6 GE Healthcare
9 Respiratory Devices, Key Marketed Products
9.1.1 Respironics V200
9.1.2 Engström Carestation
9.1.3 S9 Escape
9.1.4 Evita Infinity V500 Ventilator
9.1.5 Inspiration Elite Compressor Nebulizer System
9.1.6 525ADS Oxygen Concentrator
9.1.7 SERVO-s Ventilator
10 Respiratory Devices Market: Strategic Pipeline Assessment
10.1 Respiratory Devices in Clinical Development Stage
10.1.1 AC1 System
10.1.2 Apnex HGNS System
10.1.3 Exhale Drug Eluting Stent
10.1.4 Hattler Catheter
10.1.5 IBV Valve System
10.1.6 Portaero Pneumostoma System
10.1.7 PulseHaler
10.1.8 Zephyr Endobronchial Valve
10.2 Respiratory Devices in Early Development Stage
10.2.1 Biohybrid Artificial Lung
10.2.2 COPD Device
10.2.3 HiFLO2 Responz
10.2.4 High Density Aerosol Drug Delivery Device
10.2.5 Portable Ventilator
10.3 Respiratory Devices in Approval Phase
10.3.1 Enve Ventilator
10.3.2 Home Respiratory Clearance System
10.3.3 OneBreath
10.3.4 Pedi PAP
10.3.5 Second Generation Device
10.3.6 UltraFill Home Oxygen Filling System
10.3.7 Verso 90 Adapter
10.3.8 Hemolung
10.4 Respiratory Devices in Pre Clinical Development Stage
10.4.1 Cobra Tracheostomy
10.4.2 Fang Catheter Introducer
10.4.3 Viper Cric
11 Respiratory Devices Market: Strategic Deals Analysis
11.1 Respiratory Devices Market, Debt Offerings, 2010
11.2 Respiratory Devices Market, Mergers and Acquisitions, 2010-2011
11.3 Respiratory Devices Market, Partnerships, 2010-2011
11.4 Key Deals
11.4.1 Boston Scientific Completes Acquisition of Asthmatx
11.4.2 Dehaier Medical Enters Into Distribution Agreement with Shanghai Haopu Medical
11.4.3 Dehaier Medical Systems Signs Distribution Agreement with HEYER Medical
12 Appendix
12.1 Market Definitions
12.1.1 Respiratory Devices
12.1.2 Positive Airway Pressure Devices
12.1.3 Ventilators
12.1.4 Nebulizers
12.1.5 Oxygen Concentrators
12.1.6 Humidifiers
12.1.7 Reusable Resuscitators
12.2 Acronyms
12.3 Sources
12.4 Research Methodology
12.4.1 Secondary Research
12.4.2 Primary Research
12.4.3 Models
12.4.4 Forecasts
12.4.5 Expert Panels
12.5 Consulting
12.6 Contact Us
12.7 Disclaimer

1.1 List of Tables
Table 1: Respiratory Devices Market, Global, Revenue ($m), 2003-2010
Table 2: Respiratory Devices Market, Global, Revenue ($m), 2010-2017
Table 3: Respiratory Devices, Integrated Features
Table 4: Respiratory Devices, Global, Product Innovation
Table 5: Population Aged 65 and Above (million), Global, 2004-2010
Table 6: Positive Airway Pressure Devices Market, Global, Revenue ($m), 2003-2010
Table 7: Positive Airway Pressure Devices Market, Global, Revenue ($m), 2010-2017
Table 8: Infections Associated With PAP Machines
Table 9: Ventilators Market, Global, Revenue ($m), 2003-2010
Table 10: Ventilators Market, Global, Revenue ($m), 2010- 2017
Table 11: Ventilators, by Company
Table 12: Nebulizers Market, Global, Revenue ($m), 2003-2010
Table 13: Nebulizers Market, Global, Revenue ($m), 2010-2017
Table 14: Nebulizers Market, Average Selling Price ($), 2010
Table 15: Oxygen Concentrators Market, Global, Revenue ($m), 2003-2010
Table 16: Oxygen Concentrators Market, Global, Revenue ($m), 2010-2017
Table 17: Humidifiers Market, Global, Revenue ($m), 2003-2010
Table 18: Humidifiers Market, Global, Revenue ($m), 2010-2017
Table 19: Reusable Resuscitators Market, Global, Revenue ($m), 2003-2010
Table 20: Reusable Resuscitators Market, Global, Revenue ($m), 2010-2017
Table 21: Respiratory Devices Market, The US, Revenue ($’000), 2003-2010
Table 22: Respiratory Devices Market, The US, Revenue ($’000), 2010-2017
Table 23: Respiratory Devices Market, Canada, Revenue ($’000), 2003-2010
Table 24: Respiratory Devices Market, Canada, Revenue ($’000), 2010-2017
Table 25: Respiratory Devices Market, The UK, Revenue ($’000), 2003-2010
Table 26: Respiratory Devices Market, The UK, Revenue ($’000), 2010-2017
Table 27: Respiratory Devices Market, Germany, Revenue ($’000), 2003-2010
Table 28: Respiratory Devices Market, Germany, Revenue ($’000), 2010-2017
Table 29: Respiratory Devices Market, France, Revenue ($’000), 2003-2010
Table 30: Respiratory Devices Market, France, Revenue ($’000), 2010-2017
Table 31: Respiratory Devices Market, Italy, Revenue ($’000), 2003-2010
Table 32: Respiratory Devices Market, Italy, Revenue ($’000), 2010-2017
Table 33: Respiratory Devices Market, Spain, Revenue ($’000), 2003-2010
Table 34: Respiratory Devices Market, Spain, Revenue ($’000), 2010-2017
Table 35: Respiratory Devices Market, Japan, Revenue ($’000), 2003-2010
Table 36: Respiratory Devices Market, Japan, Revenue ($’000), 2010-2017
Table 37: Respiratory Devices Market, China, Revenue ($’000), 2003-2010
Table 38: Respiratory Devices Market, China, Revenue ($’000), 2010-2017
Table 39: Respiratory Devices Market, India, Revenue ($’000), 2003-2010
Table 40: Respiratory Devices Market, India, Revenue ($’000), 2010-2017
Table 41: Respiratory Devices Market, Australia, Revenue ($’000), 2003-2010
Table 42: Respiratory Devices Market, Australia, Revenue ($’000), 2010-2017
Table 43: Respiratory Devices Market, Brazil, Revenue ($’000), 2003-2010
Table 44: Respiratory Devices Market, Brazil, Revenue ($’000), 2010-2017
Table 45: Respiratory Devices Market, Revenue ($m), by Company, 2010
Table 46: Respiratory Diseased Population (millionGlobal, 2010
Table 47: ResMed Inc, Respiratory Devices, Marketed Products
Table 48: Philips Respironics, Respiratory Devices, Marketed Products
Table 49: Draegerwerk, Respiratory Devices, Marketed Products
Table 50: Covidien, Respiratory Devices, Marketed Products
Table 51: CareFusion Corporation, Respiratory Devices, Marketed Products
Table 52: GE Healthcare, Respiratory Devices, Marketed Products
Table 53: Respironics V200, Features and Benefits
Table 54: Engström Carestation, Features and Benefits
Table 55: S9 Escape, Features and Benefits
Table 56: Evita Infinity V500, Features and Benefits
Table 57: Inspiration Elite Compressor, Features and Benefits
Table 58: 525ADS Oxygen Concentrator, Features and Benefits
Table 59: SERVO-s Ventilator, Features and Benefits
Table 60: List of Respiratory Devices in Clinical Development Stage
Table 61: AC1 System, Product Status
Table 62: Ac1 System, Clinical Trial
Table 63: Apnex HGNS System, Product Status
Table 64: Apnex HGNS System, Clinical Trial
Table 65: Apnex HGNS System, Clinical Trial
Table 66: Exhale Drug Eluting Stent, Product Status
Table 67: Exhale Drug Eluting Stent, Clinical Trial
Table 68: Exhale Drug Eluting Stent, Clinical Trial
Table 69: Hattler Catheter, Product Status
Table 70: Hattler Catheter, Clinical Trial
Table 71: IBV Valve System, Product Status
Table 72: IBV Valve System, Clinical Trial
Table 73: IBV Valve System, Clinical Trial
Table 74: IBV Valve System, Clinical Trial
Table 75: IBV Valve System, Clinical Trial
Table 76: IBV Valve System, Clinical Trial
Table 77: IBV Valve System, Clinical Trial
Table 78: Portaero Pneumostoma System, Product Status
Table 79: Portaero Pneumostoma System, Clinical Trial
Table 80: PulseHaler, Product Status
Table 81: PulseHaler, Clinical Trial
Table 82: PulseHaler, Clinical Trial
Table 83: Zephyr Endobronchial Valve, Product Status
Table 84: Zephyr Endobronchial Valve, Clinical Trial
Table 85: List of Respiratory Devices in Early Development Stage
Table 86: Biohybrid Artificial Lung, Product Status
Table 87: COPD Device, Product Status
Table 88: HiFLO2 Responz, Product Status
Table 89: High Density Aerosol Drug Delivery Device, Product Status
Table 90: Portable Ventilator, Product Status
Table 91: List of Respiratory Devices in Approval Phase
Table 92: Enve Ventilator, Product Status
Table 93: Home Respiratory Clearance System, Product Status
Table 94: Onebreath, Product Status
Table 95: Pedi PAP, Product Status
Table 96: Second Generation Device, Product Status
Table 97: UltraFill Home Oxygen Filling System, Product Status
Table 98: Verso 90 Adapter, Product Status
Table 99: Hemolung, Product Status
Table 100: List of Respiratory Devices in Pre Clinical Development Stage
Table 101: Cobra Tracheostomy, Product Status
Table 102: Fang Catheter Introducer, Product Status
Table 103: Viper Cric, Product Status
Table 104: Respiratory Devices, Debt Offerings, 2010
Table 105: Respiratory Devices, Mergers and Acquisitions, 2010-2011
Table 106: Respiratory Devices, Partnerships, 2010-2011

1.2 List of Figures
Figure 1: Chronic Obstructive Pulmonary Disease, Symptoms
Figure 2: Sleep Apnea, Types
Figure 3: Obstructive Sleep Apnea, Pathophysiology
Figure 4: Respiratory Devices, Market Segmentation, 2010
Figure 5: Respiratory Devices Market, Global, Revenue ($m), 2003-2010
Figure 6: Respiratory Devices Market, Global, Revenue ($m), 2010-2017
Figure 7: Respiratory Devices, Market Dynamics
Figure 8: Population Aged 65 and Above (million), Global, 2004-2010
Figure 9: Smoking Population (million), The US, 2007-2009
Figure 10: Positive Airway Pressure Devices Market, Global, Revenue ($m), 2003-2010
Figure 11: Positive Airway Pressure Devices Market, Global, Revenue ($m), 2010-2017
Figure 12: Ventilators Market, Global, Revenue ($m), 2003-2010
Figure 13: Ventilators Market, Global, Revenue ($m), 2010- 2017
Figure 14: Nebulizers Market, Global, Revenue ($m), 2003-2010
Figure 15: Nebulizers Market, Global, Revenue ($m), 2010-2017
Figure 16: Oxygen Concentrators Market, Global, Revenue ($m), 2003-2010
Figure 17: Oxygen Concentrators Market, Global, Revenue ($m), 2010-2017
Figure 18: Humidifiers Market, Global, Revenue ($m), 2003-2010
Figure 19: Humidifiers Market, Global, Revenue ($m), 2010-2017
Figure 20: Reusable Resuscitators Market, Global, Revenue ($m), 2003-2010
Figure 21: Reusable Resuscitators Market, Global, Revenue ($m), 2010-2017
Figure 22: Respiratory Devices, Global, Cross-country Analysis, 2003 – 2017
Figure 23: Respiratory Devices Market, The US, Revenue ($’000), 2003-2010
Figure 24: Respiratory Devices Market, The US, Revenue ($’000), 2010-2017
Figure 25: Respiratory Devices Market, Canada, Revenue ($’000), 2003-2010
Figure 26: Respiratory Devices Market, Canada, Revenue ($’000), 2010-2017
Figure 27: Respiratory Devices Market, The UK, Revenue ($’000), 2003-2010
Figure 28: Respiratory Devices Market, The UK, Revenue ($’000), 2010-2017
Figure 29: Respiratory Devices Market, Germany, Revenue ($’000), 2003-2010
Figure 30: Respiratory Devices Market, Germany, Revenue ($’000), 2010-2017
Figure 31: Respiratory Devices Market, France, Revenue ($’000), 2003-2010
Figure 32: Respiratory Devices Market, France, Revenue ($’000), 2010-2017
Figure 33: Respiratory Devices Market, Italy, Revenue ($’000), 2003-2010
Figure 34: Respiratory Devices Market, Italy, Revenue ($’000), 2010-2017
Figure 35: Respiratory Devices Market, Spain, Revenue ($’000), 2003-2010
Figure 36: Respiratory Devices Market, Spain, Revenue ($’000), 2010-2017
Figure 37: Respiratory Devices Market, Japan, Revenue ($’000), 2003-2010
Figure 38: Respiratory Devices Market, Japan, Revenue ($’000), 2010-2017
Figure 39: Respiratory Devices Market, China, Revenue ($’000), 2003-2010
Figure 40: Respiratory Devices Market, China, Revenue ($’000), 2010-2017
Figure 41: Respiratory Devices Market, India, Revenue ($’000), 2003-2010
Figure 42: Respiratory Devices Market, India, Revenue ($’000), 2010-2017
Figure 43: Respiratory Devices Market, Australia, Revenue ($’000), 2003-2010
Figure 44: Respiratory Devices Market, Australia, Revenue ($’000), 2010-2017
Figure 45: Respiratory Devices Market, Brazil, Revenue ($’000), 2003-2010
Figure 46: Respiratory Devices Market, Brazil, Revenue ($’000), 2010-2017
Figure 47: Respiratory Devices Market, Company Share (%), 2010
Figure 48: Global Respiratory Devices Market, Company Analysis, by Segment, 2010
Figure 49: Respiratory Devices, Market Opportunities and Risk Evaluation
Figure 50: ResMed Inc, Internal Factors Evaluation
Figure 51: Philips Respironics, Internal Factors Evaluation
Figure 52: Draegerwerk, Internal Factors Evaluation
Figure 53: Covidien, Internal Factors Evaluation
Figure 54: CareFusion Corporation, Internal Factors Evaluation
Figure 55: GE Healthcare, Respiratory Devices, SWOT Analysis
Figure 56: Respiratory Devices Market, Global Pipeline Products
Figure 57: Respiratory Devices Market, Global Pipeline Products Analysis
Figure 58: Respiratory Devices Market, Deals, 2010-2011-

“Respiratory Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global respiratory devices market. The report provides market landscape, competitive landscape and market trends information on the respiratory devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

The Global Respiratory Device Market is Expected to Grow at a CAGR of 7% from 2010 to 2017

The global respiratory devices market is forecast to grow from $4.5 billion in 2010 to $7.1 billion by 2017 with a Compound Annual Growth Rate (CAGR) of 7%. The market is forecast to grow due to the increasing incidence of respiratory diseases such as asthma, sleep apnea and Chronic Obstructive Pulmonary Disease (COPD). According to the World Health Organization (WHO), there are 210 million people worldwide who are currently suffering from COPD and by 2020; COPD is expected to become the third most frequent cause of death in the world. Similarly, there are about 300 million people suffering from asthma around the world. By 2025, this number is expected to increase by another 100 million. The respiratory devices market is also expected to be driven by increasing demand for home healthcare devices and higher demand for respiratory devices in the developing countries.

Positive Airway Pressure (PAP) Devices are the Largest Market Segment in the Respiratory Devices Market

The PAP device market is the largest segment in the global respiratory devices market and accounted for almost 58% of the total revenue generated in 2010. The PAP device segment will continue to witness high growth and remain as the largest segment in future. The global market for PAP is forecast to grow from $2.6 billion in 2010 to about $4.4 billion by 2017, with a CAGR of 8%. Availability of reimbursement for the PAP devices is expected to drive the market growth.

ResMed Inc
Philips Respironics, Inc.
Draegerwerk AG & Co. KGaA
Covidien plc
CareFusion Corporation
GE Healthcare

Customers who bought this item also bought

• Gene Amplification Technologies - Global Strategic Business Report
• Biotechnology Instrumentation - Global Strategic Business Report
• Biotechnology Reagents - Global Strategic Business Report
• Molecular Cytogenetics - Global Strategic Business Report
• Electronic Access Control Systems - Global Strategic Business Report
• Proteomics - Global Strategic Business Report
• Global Biopharmaceutical Market Report & Forecast (2012-2017)
• Biobanks - Global Strategic Business Report
• RNA Interference (RNAi) - Global Strategic Business Report
• Automated and Rapid Microbiological Tests - Global Strategic Business Report